Diabetes Research and CBD (Cannabidiol)
CBD Oils and Nicotine Addiction
Quitting Smoking Mandatory for Good Health Cigarette smoking is the leading cause of preventable disease and death in the U.S. You may know the specifics but smoking butts causes colorectal cancer, liver cancer, adverse health outcomes in cancer patients and people with heart disease, lung diseases and chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis. Smoking also... ContinueHow CBD Can Combat Oxidative Stress
How CBD Can Combat Oxidative Stress Increasingly, research has shown that cannabinoids like cannabidiol (CBD) can play a major role in the body’s multidimensional biochemical balancing act known as homeostasis. One its most beneficial properties is the potential role in helping the body deal with oxidative stress caused by free radicals. What Are Free Radicals? Free radicals are chemical species... Continue
Diabetes Research Continued
- The impact of marijuana use on glucose, insulin, and insulin resistance among US adults
- CBD attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
- CBD lowers incidence of diabetes in non-obese diabetic mice
- Neuroprotective and blood-retinal barrier-preserving effects of CBD in experimental diabetes
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice
- Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
- Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
- The endocannabinoid system in obesity and type 2 diabetes
- Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
- The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications
- Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
- Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats
